Documentation Centre

 

 

  of 178 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2296-304 March 02, 2015 Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2296-304 Thomopoulos C, Parati G, Zanchetti A Key Publications
Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk--overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2305-14 March 02, 2015 Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk--overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2305-14 Thomopoulos C, Parati G, Zanchetti A Key Publications
Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014;32:2285-95 February 27, 2015 Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014;32:2285-95 Thomopoulos C, Parati G, Zanchetti A Key Publications
Dairy product consumption has no impact on biomarkers of inflammation among men and women with low-grade systemic inflammation. J Nutr. 2014;144:1760-7 February 12, 2015 Dairy product consumption has no impact on biomarkers of inflammation among men and women with low-grade systemic inflammation. J Nutr. 2014;144:1760-7 Labonté MÈ, Cyr A, Abdullah MM, Lépine MC, Vohl MC, Jones P, Couture P, Lamarche B Key Publications
Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis. J Hypertens. 2015;33:243-54 January 30, 2015 Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis. J Hypertens. 2015;33:243-54 Li G, Zhang Y, Thabane L, Mbuagbaw L, Liu A, Levine MA, Holbrook A Key Publications
Coronary artery disease: HDL and coronary heart disease-novel insights. Nat Rev Cardiol. 2014;11:559-60 January 06, 2015 Coronary artery disease: HDL and coronary heart disease-novel insights. Nat Rev Cardiol. 2014;11:559-60 Landmesser U Key Publications
Weight loss effects from vegetable intake: a 12-month randomised controlled trial. Eur J Clin Nutr. 2014;68:778-85 October 06, 2014 Weight loss effects from vegetable intake: a 12-month randomised controlled trial. Eur J Clin Nutr. 2014;68:778-85 Tapsell LC, Batterham MJ, Thorne RL, O'Shea JE, Grafenauer SJ, Probst YC Key Publications
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA. 2014;311:2387-96 September 19, 2014 Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA. 2014;311:2387-96 Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, Espeland MA, Fielding RA, Gill TM, Groessl EJ, King AC, Kritchevsky SB, Manini TM, McDermott MM, Miller ME, Newman AB, Rejeski WJ, Sink KM, Williamson JD; LIFE study investigators Key Publications
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. J Am Coll Cardiol. 2014;63:2541-8 September 15, 2014 Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. J Am Coll Cardiol. 2014;63:2541-8 Stroes E, Colquhoun D, Sullivan D, Civeira F, Rosenson RS, Watts GF, Bruckert E, Cho L, Dent R, Knusel B, Xue A, Scott R, Wasserman SM, Rocco M; GAUSS-2 Investigators Key Publications
Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab. J Am Coll Cardiol. 2014;63:2531-40 September 12, 2014 Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab. J Am Coll Cardiol. 2014;63:2531-40 Koren MJ, Lundqvist P, Bolognese M, Neutel JM, Monsalvo ML, Yang J, Kim JB, Scott R, Wasserman SM, Bays H; MENDEL-2 Investigators Key Publications

  of 178 Next page

Go to page: of